The goal of this activity is for the learner to be better able to understand the evidence supporting neuroinflammation and oxidative stress as new mechanisms of AD pathology and emerging therapeutic targets, as well as the biomarkers associated with changes along the AD trajectory.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1000023
- Start Date: 2024-02-15 06:00:00
- End Date: 2024-02-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 155025.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine
Subscribe
Login
0 Comments
Oldest